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Abstract 
Metabolic engineering of cellular systems to maximize reaction fluxes or metabolite concentrations still 
presents a significant challenge by encountering unpredictable instabilities that can be caused by 
simultaneous or consecutive enhancements of many reaction steps. It can therefore be important to select 
carefully small subsets of key enzymes for their subsequent stable modification compatible with cell 
physiology. To address this important problem, we introduce a general Mixed Integer Non-Linear 
Problem (MINLP) formulation to compute automatically which enzyme levels should be modulated and 
which enzyme regulatory structures should be altered to achieve the given optimization goal using 
nonlinear kinetic models of relevant cellular systems. The developed MINLP formulation directly 
employs a stability analysis constraint and also includes nonlinear biophysical constraints to describe 
homeostasis conditions for metabolite concentrations and protein machinery without any preliminary 
model simplification (e.g. linlog kinetics approximation). The framework is demonstrated on a well-
established large-scale kinetic model of the Escherichia coli central metabolism used for the optimization 
of the glucose uptake through the phosphotransferase transport system (PTS) and serine biosynthesis. 
Computational results show that substantial stable improvements can be predicted by manipulating only 
small subsets of enzyme levels and regulatory structures. This means that while more efforts can be 
required to elucidate larger stable optimal enzyme level/regulation choices, no further significant increase 
in the optimized fluxes can be obtained and, therefore, such choices may not be worth the effort due to the 
potential loss of stability properties. The source for instability through saddle-node and Hopf bifurcations 
is identified, and all results are contrasted with predictions from Metabolic Control Analysis. 
 
Kew words: Mixed Integer Non-Linear Problem (MINLP), simulated annealing, sequential quadratic 
programming, biochemical engineering of cellular systems, kinetic models 
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1. Introduction 
A systematic development of optimal bioprocesses and application of metabolic engineering in 
biotechnology and biomedical studies requires a deep understanding of microbial organization 
and function (Bailey 1991; Stephanopoulos et al. 1998). While bioinformatics tools and related 
technology will continue to dominate in the field within the next decade (Overbeek et al. 2005), 
these efforts are, by themselves, insufficient and should be complemented by the development of 
alternative tools to relate static genomes to dynamic nonlinear cellular physiology and population 
response. One way to approach this goal is to construct plausible mathematical models 
incorporating relevant molecular details (Bailey 1998; Palsson 2006; Shuler 2005; Tomita 2001). 
Intrinsic complexity of cellular systems and, as a result, of the corresponding mechanistic models 
necessitates further development of modeling concepts and computational tools to rapidly extract 
valuable information from such complex models. 
Mathematical models have been extensively used in microbiology since the Monod’s 
discovery of the relationship between the specific growth rate and the concentrations of limiting 
substrates (Monod 1949). Microbial population studies can now be complemented by nuclear 
magnetic resonance (NMR) experiments to measure intracellular fluxes and metabolite levels, 
which can be economically designed using multi-level computational optimization-based 
frameworks employing stoichiomertic reaction networks (Ghosh et al., 2006). Credible 
overproduction strategies have recently been suggested based on cellular stoichiometry alone 
(Alper et al. 2005; Burgard et al. 2003, 2004; Ibarra et al. 2002; Lee et al. 2005, 2006; Pharkya et 
al. 2004; Pharkya and Maranas 2006). Because stoichiometry does correctly define overall 
barriers and limits for steady state reaction fluxes under fixed ‘defined medium’ constraints, 
genome-scale stoichiometric models have been very successful in many instances in fundamental 
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and applied research (Palsson 2006). However, predictive capability of such stoichiometric 
models is limited to calculations of ‘instant phenotype snapshots’ and, therefore, such models 
cannot capture non-stoichiometric dynamic effects (Mahadevan et al. 2002), enzyme regulation 
(Pharkya et al. 2003), and dynamic responses in protein machinery and genetic control (Laffend 
and Shuler 1993; Schmid et al. 2004). Alternative advances toward the rational analysis of 
cellular function are known as Metabolic Control Analysis (MCA) (Heinrich and Rapoport 1974; 
Kacser and Burns 1973) and Biochemical Systems Theory (BST) (Savageau 1976).  
 The MCA, linlog and BTS approaches have been successfully used to improve control 
architectures in metabolic reaction networks (Hatzimanikatis et al. 1996ab). Their method has 
been recently generalized by Vital-Lopez et al. (2006) to include knockouts by proposing a 
general computational procedure determining which genes/enzymes should be eliminated (i.e. 
knocked out), repressed or overexpressed to maximize the metabolic flux of interest. In that 
work, automatic linearizations according to basic function approximations for arbitrary kinetic 
representations are combined with binary variables introduced to remove reactions from the 
linearized kinetic model. Insightful ‘universal’ perturbation methods were developed to increase 
desired concentrations and fluxes within complex networks (Kacser and Acerenza 1993; Small 
and Kacser 1994). Based on this universal approach, a conception of group flux and 
concentration control coefficients was introduced and then used for the optimal selection of 
small subsets of key enzymatic reactions with the maximum impact on the targeted flux 
(Stephanopoulos and Simpson 1997). The metabolic design analysis based on the moiety 
conservation information has been recently discussed in the context of genome-scale conserved 
moiety pools spanning many metabolic subsystems (Nikolaev et al. 2005). 
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 Although the discussed analyses are based on important approximations (Heijnen 2005) 
of inherently nonlinear metabolic pathways, genetic manipulations can however cause metabolic 
networks to deviate significantly from the original stationary state. Besides, both stoichiometric 
flux balance (FBA) and MCA do not provide any means to check the stability of predicted 
optimal states. Simultaneous or consecutive modifications of many reaction steps can often lead 
to unpredictable instabilities and, therefore, can be experimentally infeasible (Stephanopoulos 
and Simpson 1997). In response to these limitations and challenges, a number of research groups 
have undertaken the development of plausible large-scale kinetic models. Prominent modeling 
projects include large-scale kinetic models of Saccharomyces cerevisiae (Hynne et al. 2001; 
Rizzi et al. 1997) and Escherichia coli (Chassagnole et al. 2002; Visser et al. 2004), the kinetic 
model of central metabolism coupled with tryptophan gene expression in E.coli (Schmid et al. 
2004), and computer models of single cells capturing dynamic effects of chromosome replication 
and changes in the cell geometry (Atlas et al., 2008; Castellanos et al. 2007; Domach et al. 1984; 
Nikolaev et al. 2006). The discussed models are highly nonlinear, stiff and include many kinetic 
parameters which are hard to identify from the measurements. To reduce the model stiffness and 
to minimize the number of kinetic parameters, an important advantage in the current problem of 
parameter identifiability, rigorous mathematical and computational frameworks have been 
recently developed (Gerdtzen et al., 2004; Nikerel et al., 2009). Different approximation 
frameworks require the development of powerful algorithms allowing for the evaluation of 
information contents and predictive capabilities of such approximations by translating 
biochemical models from one kinetic format to another (Hadlich et al., 2009).  
While the discussed optimization-based frameworks essentially utilize similar concepts 
based on the traditional linearization and linlog approximation, combined with a Mixed Integer 
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Linear Programming (MILP) approach, the goal of this work is substantionally different. For the 
first time, we introduce a large-scale nonlinear optimization computational approach which 1) 
can be applied to the original kinetic model without any preliminary model simplification such as 
linearization and size reduction which could result in potential loss of important (e.g. nonlinear 
dynamics) information; 2) utilizes a more general nonlinear optimization formulation; 3) 
includes explicitly a stability constraint to detect unstable optimal solutions and the type of 
bifurcation; and 4) allows for the straightforward incorporation of additional important context-
dependent biophysical nonlinear constraints. The developed approach is based on a general 
Mixed Integer Non-Linear Problem (MINLP) formulation to compute automatically which 
enzyme levels should be modulated and which enzyme regulatory structures should be altered to 
achieve the given optimization goal. To solve a complex MINLP formulation, a hybrid 
deterministic-stochastic computational method is used. Specifically, a stochastic simulated 
annealing is employed to navigate through the discrete space of enzyme levels and regulatory 
structures, while a sequential quadratic programming method is utilized to identify optimal 
enzyme levels and regulatory kinetic parameters. The framework is demonstrated on a well-
established kinetic model of the E. coli central metabolism (Chassagnole et al. 2002), used for 
the optimization of the glucose uptake through the phosphotransferase transport system (PTS) 
and serine biosynthesis. 
 
2. Mathematical Model  
A mathematical model of relevant processes in cellular metabolism and protein machinery can 
be represented in the form (Laffend and Shuler 1993; Mauch et al. 2001; Schmid et al. 2004). 
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Here Ci is the concentration of metabolite i, Sij is the stoichiometric coefficient of metabolite i in 
reaction j with rate ),,max( KRC,jrjr , 
max
jr  is the maximal specific rate of reaction j; C is the 
vector of metabolite concentrations, R is the vector of all regulatory parameters (e.g. allosteric 
parameters), and K is the vector of all other kinetic parameters (e.g. Michaelis-Menten constants 
etc.). The index sets N  = {1,…,N}, M  = {1,…,M}, and R  = {1,…,R} correspond to all 
metabolites, reactions, and regulatory parameters, respectively. 
 Let je  be the level of the enzyme catalyzing reaction j. We introduce enzyme level/regulation 
subset SD of size D, SD = EL U RQ, which is constructed of the two subsets, EL of modulated 
enzyme levels and RQ of altered regulatory parameters. EL corresponds to a subset of enzyme 
levels ),...,(
1 Ljj ee  or, equivalently, maximal specific rates, ),...,( maxmax1 Ljj rr , EL = {j1,…,jL}, 
EL ⊆  M , L ≤ M. Set RQ corresponds to a subset of regulatory parameters ),...,( 1 Qkk θθ , 
RQ = {θ1,…, θQ}, RQ ⊆  R , Q ≤ R, D = L + Q. Following these definitions, we use model (1) for 
the optimal selection of set SD such that the best possible reaction rate ), ,( max00 KRC, rr jj  can be 
achieved for targeted enzyme j0 of interest. 
Since detailed mechanistic equations describing dynamic changes in all enzyme levels je  
are not available, reasonable context-dependent modeling assumptions and ‘coarse-grained’ 
approximations are necessary. We follow a general approach (Chassagnole et al. 2002; Mauch et 
al. 2001), accounting for homeostasis and limited protein biosynthesis machinery in the cell. To 
capture the cell’s limited protein biosynthesis efforts, constraint (2) is used,  
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Constraint (2) can be interpreted as a stress-related restriction for allowable genetic 
manipulations that could otherwise potentially lead to crowding of overexpressed enzymes. Due 
to the homeostasis condition, allowable concentration changes  relative to the original stationary 
concentrations C0 should also be restricted, 
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Equation (1), constraints (2) and (3) are still, by themselves, insufficient to describe coordinated 
changes in both modulated and non-modulated enzyme levels. In the previous optimization-
modeling studies (Schmid et al. 2004; Vital-Lopez et al. 2006), this issue is approached by 
assuming that the levels of all non-modulated enzymes can be kept unchanged. However, 
experimental observations show that overexpression of even one enzyme can already lead to a 
significant decrease in all other enzyme levels as reported, for example, for Zymomonas mobilis 
(Bakker et al. 1995). Based on this observation, we introduce constraint (4) to generalize a 
complex systems response of the protein-synthesizing system (PSS) as described below in detail, 
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.  (4) 
Here ''1,..., Kjj  are the indices of non-modulated enzymes, K  = M - L, L is the number of 
modulated enzymes, and γ is a proportionality coefficient chosen for simplicity uniformly for all 
non-modulated enzymes as discussed below. Coefficient γ can be calculated from (2) and (4) as  
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The control of PSS, consisting of ribosomes, mRNA, tRNA, and the enzymes that make and 
modify these molecules is very complex. Therefore, additional modeling assumptions are 
required to formalize the complex processes. Following (Segre et al. 2002), we derive the 
approximation of the adjustments for the non-modulated enzyme levels (4) by assuming that the 
perturbed cell attempts to preserve the ratios between non-modulated enzyme activities equal or 
close to those established at the reference non-perturbed ‘wild-strain’ cell, 
  .0max,
0max,
max
max
'
'
'
'
q
p
q
p
j
j
j
j
r
r
r
r
≈  (6) 
Here, p ≠ q, and p and q correspond to non-modulated enzyme levels. Eq. (6) may be interpreted 
as corresponding to important cellular function when it is the ratio of specific rates and not their 
absolute magnitudes may be important and preserved (Browning and Shuler 2001). Using simple 
algebraic manipulations, (6) can be transformed to the equivalent form 
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Using γ=0max,max
''
/
qq jj
rr  in (7) and then approximating (7) by the exact equality, we obtain  
  .0max,
max
0max,
max
'
'
'
'
γ==
q
q
p
p
j
j
j
j
r
r
r
r
 (8) 
We note that (4) is equivalent to (8). When more molecular details on the complex protein 
machinery become available, (4) can be replaced by more accurate mechanistic equations 
without affecting the presented modeling framework. 
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 Model (1) incorporates 30 enzymes and 13 enzyme regulatory structures shown in Table 1 
and Figure 1. Because enzyme regulation can be extremely complex by  encompassing many 
kinetic parameters (Chassagnole et al. 2002), we have implemented 13 additional dimensionless 
‘generalized regulatory’ parameters ( 131 ,...,αα ) to activate or disable the entire regulatory 
structures. The modified model includes 43 optimization parameters ),...,( 431 pp , 
),...,,,...,(),...,( 131maxmax431 301 ααrrpp = . The simplest example is phosphoglucoisomerase (PGI) 
inhibition by 6-phosphoglucoconate (6pg), 
  
g6p
6pginhg6p,PGI,
6pg
2
6pginhf6p,PGI,
6pg
2f6pPGI,
f6p
g6pPGI,
eqPGI,
f6p
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PGI
)
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1
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1(
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C
K
C
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C
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C
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K
C
Cr
r
+⋅+
+
⋅+⋅
+⋅
−⋅
=
α
α
 .  (9) 
Here parameter 2α  is introduced to alter the regulatory properties of PGI mediated by the 
concentration of 6-phosphogluconate (i.e. 6pgC ). Specifically, the unit value of 2α  (i.e. 12 =α ) 
corresponds to the original enzyme regulatory properties, while altered values, 12 <α  or 12 >α , 
correspond to decreased or increased regulation of PGI by C6pg, respectively.  
 
3. Computational Method 
3.1. Mixed Integer-Non-Linear Problem (MINLP) formulation 
To select alternative optimal targets for practically feasible modulations of enzyme levels and 
genetic mutations of regulatory properties (e.g., inhibitory affinities), optimal solutions of the 
following Mixed Integer Non-Linear Problem (MINLP) are calculated,  
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The first constraint in (10) corresponds to the steady state in (1). The second and third constraints 
result from the protein limited biosynthesis constraint (2) and the conditions for non-modulated 
enzymes (4) and (5), respectively. The forth constraint is the homeostasis condition (3). The fifth 
constraint enforces the optimal solution stability property. Here iλRe  is the real part of 
eigenvalue iλ  calculated from the linearization of the right-hand side of equation (1) at the 
steady state concentrations, and 0λ  is an appropriate small positive number. Formulation (10) 
allows for the simultaneous elucidation of two optimal subsets EL (i.e. a subset of modulated 
enzyme levels) and RQ (i.e., a subset of altered regulation parameters), SD = EL U RQ, such that 
the best possible targeted rate ),,,( max
00
KRCjj rr  can be achieved. In (10), the indices of enzyme 
levels and regulatory parameter correspond to integer variables, while the magnitudes of the 
enzyme levels and regulatory parameters correspond to continuous variables. 
 
3.2. Computational implementation 
The optimization framework and MINLP formulation (10) have been demonstrated on a large-
scale nonlinear model of central carbon metabolism for a glucose-limited culture of E. coli 
(Chassagnole et al. 2002). The model is comprised of 30 enzymes and 17 metabolites with the 
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objective of maximizing fluxes through the phosphotransferase system (PTS) and serine 
production reaction (see Figure 1). Initial reference values of non-perturbed specific maximal 
rates (i.e., 0max,r ), kinetic parameters, and steady state metabolite concentrations (i.e. C0) have 
been used as suggested in (Chassagnole et al. 2002). 
 To solve (10) numerically, we have implemented a simulated annealing (SA) algorithm 
(Kirkpatrick et al. 1983) to navigate through the discrete space of enzyme levels M  and 
regulatory parameters R . In our approach, subsets SD of increasing fixed sizes D, D = 1, …, 10, 
are separately investigated, where D = L + Q,  L and Q are the numbers of modulated enzyme 
levels and altered regulatory parameters, respectively. For each randomly selected SD, the 
optimal values of specific reaction rates ),...,( maxmax
1 Ljj
rr  and regulatory parameters (
Qθθ
αα ,...,
1
) 
are calculated by utilizing gradient-based algorithms (e.g. an SQP-algorithm). To evaluate 
rate ),( max
00
KR,CSS, rr jj , steady state concentrations Css are calculated using Newton-based 
solvers. Because Newton-based solvers can converge to both stable and unstable solutions, the 
stability of Css is investigated by computing the eigenvalues of the Jacobian matrix readily 
available from such solvers.  
 Random multistarts have been used to check the robustness of the SQP search and no 
alternative global optima was found as earlier reported by Visser et al. (2004). Tight absolute 
(i.e. abs = 10-11 - 10-9) and relative (i.e. rel = 10-9-10-7) tolerances have been enforced to keep 
integration errors low due to the enormous ‘stiffness’ of the model. Also, δ = 0.1 is used in (3) 
for an allowable 10% change in the metabolite concentrations to preserve stability properties. 
The optimization modeling framework is implemented in Matlab on a Linux cluster with Intel 
CPU 3.06 GHz computers. Typical computational requirements are in order of minutes for small 
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SL+Q (i.e. with L + Q ≤ 3), up to 30-40 hours for large enzyme subset SL (i.e. with Q = 0), and up 
to 60-90 hours for large enzyme level/regulation subsets SL+Q (i.e. with Q > 0).  
 
4. Results and Discussion 
4.1. Comparative analysis of optimally selected subsets 
The best found flux ratios for PTS and serine (i.e. SerSynth) rates in the optimized and original 
models, respectively, are presented in Table 2 for the following three distinct cases: (i) all 13 
generalized regulatory parameters are altered, while all enzyme activities are kept unchanged, (ii) 
all 30 enzyme levels are modulated, while regulatory parameters are kept fixed, and (iii) the 
maximum possible number of enzyme levels and regulatory parameters is manipulated until the 
pathway stability is lost. We find from Table 2 that the alteration of enzyme regulation alone 
does not lead to any significant improvement in the targeted fluxes. This can be explained by a 
limited capacity of an enzymatic reaction to ‘channel’ a large flux without a substantial increase 
in the enzyme specific activity. At the same time, no further impressive increase in the serine 
flux has been observed compared to the modulation of enzyme levels alone (see Table 2). These 
observations are biologically meaningful since PTS is a tightly regulated enzyme, while the 
SerSynth reaction lacks any kind of pathway regulation (see Figure 1).  
 The analysis of small optimal enzyme level/regulation subsets leads to the following facts and 
conclusions. First of all, substantial improvements in the desired fluxes can be predicted by 
manipulating only small enzyme level subsets (see Figure 2a and 3a). We find that no substantial 
increase in the desired PTS and serine flux can be obtained for the best mixed enzyme/regulation 
subsets of small sizes (i.e., D = 1, 2, and 3) (solid circles in Figure 2a and 3a, respectively), 
compared to enzyme level modulations alone (white circles in Figure 2a and 3a, respectively). 
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For larger mixed enzyme level/regulation choices, a significant additional flux increase can be 
predicted, though at the expense of the loss of stability properties due to the attenuation of 
negative feedbacks, evolved to ensure the robustness of cellular systems, and the amplification of 
positive feedbacks always destabilizing the cellular system. Specifically, we could not find any 
stable optimal steady state solution for the serine overproduction by navigating enzyme 
level/regulation subsets of size 8, 9 and 10, where the saddle-node bifurcation (Kuznetsov 2004) 
leading to the disappearance of steady state solutions was detected. This conclusion is supported 
by plotting the values of the leading real eigenvalue that sharply tends to the zero level around 
the subset size 7 as depicted in Figure 2b. Beyond the bifurcation point, solutions to (1) became 
unbounded violating homeostasis constraint (3). The disappearance of the pathway stable steady 
state can be interpreted by the loss of the balance between the increased large demand for the 
serine biosynthesis and the limited activity of the cellular system which cannot support the non-
physiologic product demands. This observation is in line with the bifurcation analysis of the 
model (Vital-Lopez et al., 2006). Despite the importance of the situation for the dynamic 
optimization, we have not studied the dynamics of the system in detail after the loss of stability. 
Indeed, the model and its parameters are carefully selected to study stationary regimes only. 
Specifically, the concentrations of all co-factors, ATP, ADP, AMP, NAD, NADH, NADP and 
NADPH are kept fixed under stationary physiological conditions (Chassagnole et al. 2002). 
Therefore, freeing the co-factor concentration is needed to study the dynamic regimes beyond the 
model applicability condition limited to stable steady states.  
 The Hopf bifurcation giving rise to small amplitude stable periodic oscillations has been 
encountered in the case of the PTS optimization for mixed enzyme level/regulation subsets of 
size 8, 9, and 10. Plotting the real parts of the leading eigenvalue has revealed multiple solution 
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branches and their bifurcations as depicted in Figure 3. We observe that for the mixed enzyme-
regulation subsets, the corresponding optimal steady-state solution loses it stability via a saddle-
node bifurcation when the subset size is 5. However, another branch of optimal steady-state 
solution does exist when the subset size is 6. The latter stead-state solution branch then loses its 
stability via a Hopf bifurcation when a couple of complex-conjugated pairs of eigenvalues 
crosses the imaginary axis in the complex plane (Kuznetsov 2004).  The steady-state solution 
does not disappear at the Hopf bifurcation point and, instead, becomes unstable for the cases of 
the mixed subsets of size 8, 9, and 10. Here, a branch of stable two-dimensional small amplitude 
sinusoidal limit cycles emanates from the critical steady-state at the bifurcation moment. 
Although the stability of limit cycles can be practically checked by direct integration, we note 
that the stability of the periodic solutions near the Hopf point can also be systematically 
determined by calculating appropriate nonlinear terms in the Taylor series at the critical steady 
state (Khazin and Shnol, 1991; Kuznetsov, 2004). The appearance of oscillations can be 
attributed to the well-known autocatalytic properties of glycolysis (Heinrich and Schuster 1996), 
enhanced by the increased glucose uptake through the optimized PTS. Similarly to the 
bifurcation analysis done in (Vital-Lopez et al., 2006), only small-amplitude periodic regimes 
existing within small parameter regions have been identified and no large-amplitude regime has 
been found from the stochastic search. This model’s inability to generate large-amplitude 
oscillations can again be attributed to the model intrinsic properties limited to the steady-state 
conditions by freezing the co-factor concentrations. 
 Although the model utilized in this study cannot be used to suggest dynamic optimal 
engineering strategies far from the reference steady-state, the observed small-amplitude periodic 
regimes can provide important insights into the potential of oscillatory optimal states compared 
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to the optimal steady-state conditions. To compare optimal small-amplitude periodic and steady-
state predictions, we have averaged the solutions along the observed periodic solutions and 
plotted the data on Figure 2a. We observe a noticeable increase in the optimal averaged PTS rate 
for the small-amplitude periodic processes compared with the stead-state case. Given the fact 
that the annual production of amino-acids worldwide is approximately two million metric tons 
(Pharkua et al., 2003), the observed increase in the PTS rate can lead to a significant 
improvement in certain amino-acid production, when recalculated using absolute values. We 
emphasize that these preliminary studies require further analysis that goes beyond the scope of 
this work as summarized in the conclusion and outlook section below. 
 In all cases considered, the calculations demonstrate a saturation type of the optimal behavior 
for the entire reaction network (see Figure 2 and 3) due to the fixed external conditions and the 
imposed protein limiting machinery constrains (2) - (4). This means that while more efforts can 
be required to elucidate larger stable optimal enzyme level/regulation choices, no further 
significant achievement in the corresponding targeted flux can be obtained and therefore such 
choices may not be worth the effort. 
 
4.2. Calculation of control coefficients 
To obtain quantitative insights into how successive small enzyme level/regulation subsets can be 
selected to meet overproduction requirements, MCA can be used to calculate sensitivity and 
control coefficients (Stephanopoulos et al. 1998). Taking into account that both enzyme levels 
and kinetic regulatory parameters can significantly contribute to the targeted pathway flux J, the 
following coefficients have been evaluated, (i) the flux control coefficient (FCC), 
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(ii) the flux response coefficient (FRC) with respect to a regulatory parameter (i.e. α), 
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(iii) the enzyme elasticity coefficient (EEC) quantifying the potential of parameter α to affect the 
individual reaction rate r under isolated conditions, 
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Coefficients JR
α
, 
J
rC , and 
r
απ  satisfy the simple identity (Heinrich and Schuster 1996), 
  ≡JRα
J
rC ·
r
απ .  (14) 
Using a log-log finite-difference approximation of (11) - (13), identity (14) has been numerically 
checked to ensure the robustness of all numeric calculations in the stiff model (see Table 3).  The 
calculated control coefficients reveal a distributed control on the targeted fluxes, allocated within 
a group of several rate-limiting steps exerting the highest control as seen from Figure 3. Namely, 
the same group of rate limiting steps (i.e., PTS, PFK, GAPDH, PDH, PEPxylase, and G6PDH) is 
identified for potential practical enzyme level modulations and regulatory structures genetic 
mutations for both cases of the PTS and serine optimizations. Since the control coefficients are 
readily available from the measurements (Stephanopoulos et al. 1998), we will compare local 
MCA-based predictions with those obtained from the nonlinear optimization framework. 
 
4.3. The PTS rate optimization results 
We begin with the discussion of the best enzyme level choices presented in the left side of Table 
4. First, the best enzyme level choices are in most cases found to be in a good agreement with the 
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MCA-based predictions. However, the detailed analysis of Table 4 reveals that both local FCC-
based and nonlinear optimization predictions lack the additivity property in a sense that the best 
enzyme choices alone cannot be combined with one another to significantly improve the PTS 
rate. For example, the triplet of enzymes PTS, phosphofructokinase (PFK), and pyruvate 
dehydrogenase (PDH) exerting the highest total control (see Figure 3) is absent from Table 4. 
These enzymes are present in all larger subsets (i.e., with D ≥ 5). Importantly, while MCA 
suggests decreasing the level of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) exerting 
high negative control (see Figure 3), the level of this enzyme is increased in all nonlinear 
optimization studies (see Table 4). This observation is in line with the previous optimization 
study (Visser at al., 2004). Therefore, even for a rate limiting step with a high control coefficient, 
the direction of the corresponding enzyme level modulation cannot be solely predicted by MCA 
alone. We also find from Table 4 that almost half of all modulated enzymes present in larger 
subsets are near-equilibrium enzymes exerting negligibly small control coefficients. Note that 
which of such near-equilibrium enzymes should be modulated cannot be predicted from MCA.  
 The optimization results also show how the best enzyme level choices emerge. Although, the 
best choices lack the additivity property, the best smaller choices repeatedly enter the best larger 
subsets (see Table 4). This means that control of flux does not shift between different groups of 
enzymes due to the compensating effects of global regulation and homeostasis. The absence of 
the shift in distributed control additionally emphasizes the importance of reaction steps with high 
values of control coefficients for enzyme subsets of different size. 
 Enzymes with large flux control coefficients are not always the ones to be modified, 
especially if they are involved in feedback control loops. It may be the removal or attenuation of 
certain negative-feedback loops that should be considered and not the amplification of the 
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activity of the corresponding enzymes (Bailey 1991; Hatzimanikatis et al. 1996b; 
Stephanopoulos and Vallino 1991).  These and similar important theoretic predictions are 
exemplified by the optimal selection of the best mixed enzyme level/regulation choices, 
presented in the right side of Table 4. Importantly, the regulatory properties (see Table 1) and not 
enzyme levels of all three tightly regulated enzymes, PTS (i.e. PTS↓g6p(-)), PFK (i.e. 
PFK↑amp(+)), and PEPxylase (i.e. PEPxylase↑fdp(+)), have been chosen to alter, while their 
levels were automatically adjusted due to the limited protein machinery constraints (4) and (5). 
These nonlinear optimization observations are also found in a good agreement with calculations 
of response coefficients presented in Table 3. For example, the amplification of the positive 
regulation of PFK by amp (i.e. PFK↑amp) with FRC = 0.065 is more preferable than the 
amplification of the positive feedback by adp (i.e. PFK↑adp) with FRC = 0.00605. Although 
many enzymes are present in both left and right sides of Table 4, different manipulations of these 
enzymes are automatically suggested by the computational procedure, based on the presence or 
absence of regulatory structures in the selected enzymes. 
 Figure 5 further compares flux control coefficients and relative optimal enzyme levels, 
calculated for the six best enzyme choices selected to increase the PTS flux (i.e. PTS, PFK, TIS, 
GAPDH, PDH, and PEPxylase in Table 4). The corresponding distributions of steady state 
fluxes are shown in Figure 6. The levels of the modulated enzymes (see Figure 5(b)) are for the 
most part proportionally changed accordingly to the changes in their flux control coefficients.  
Specifically, the change in the sign of the FCCs for GAPDH (i.e., negative values are changed to 
positive values) correctly predicts a substantially increased level of the enzyme when both the 
enzyme levels and the regulation of all selected enzymes are allowed to vary. 
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4.4. The serine optimization results 
Similar results have been obtained for the optimization of the serine production flux as shown in 
Table 5. We note that small enzyme/regulation choices are intuitive as the PTS (i.e. PTS(+) in 
Table 5) supplies metabolism with the initial substrate, while SerSynth (i.e. SerSynth(+) in 
Table 5) leads to the final serine production. Similarly to the case of the PTS flux optimization, 
larger enzyme level/regulation choices encompass enzymes with both high and negligibly low 
values of FCCs. 
 Because of the importance of the robustness and stability issues for application, we have 
chosen two intermediate cases of (i) the best six enzyme levels PTS(+), PFK(+), GAPDH(+), 
TIS(-) , PDH(+), SerSynth (+), and (ii) the best mixed enzyme level/regulation choices, 
PTS↓g6p(-), PFK↑amp(+), GAPDH(+), TIS(+), PDH(+), SerSynth (+), to discuss the optimal 
enzyme activities and regulatory properties in more details (see Table 5). Recall that these cases 
already provide an increase in the serine production of about 80% of the best predictions shown 
in Figure 2(a) (white and solid circles). The optimal distributions of the steady state fluxes 
allocated within the pathway towards the serine overproductions are shown in Figure 8. We find 
that an increase in the serine demand (see Figure 7(b)) reallocates the strength of metabolic 
control from the serine synthesis (SerSynth in Figure 7(a)) towards the supply block (i.e. PTS) 
and the pyruvate removal block (i.e. PDH) (see Figure 7(a)).  
 Although the nonlinear optimization observations are in many cases found in a good 
agreement with calculations of response coefficients (RFC) presented in Table 3, there are 
several discrepancies. For example, the amplification of the positive regulation of PFK by amp 
(i.e. PFK↑amp) with small FRC = 0.0376 calculated in Table 3 has proved to be more preferable 
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than the attenuation of the negative feedback by pep (i.e. PFK↓pep as in Table 1) with FRC = -
0.287 of much larger magnitude. 
  The optimization results do confirm the importance of high flux control coefficients, 
estimated at the reference (‘wild-type’) strain which in many cases correctly delineate the most 
important blocks of central metabolism from less important subordinate pathways. Specifically, 
flux is increased through phosphotransferase system (PTS), phosphofructokinase (PFK), a 
committed enzyme in the network, and pyruvate dehydrogenase (PDH) required to removing an 
excess of pyruvate accumulated through the enhanced PTS. Comparing the best enzyme choices 
for the optimal PTS rate and serine flux, we come to a very important observation that in both 
cases the best choices emerge in a similar fashion signifying a common trend in the selection of 
candidate enzyme/regulation subsets, where the best smaller choices repeatedly enter the best 
larger subsets. This property can be apparently attributed to the homeostasis condition and 
negative feedback which attempt to stabilize the system. However, more research is needed to 
support or disprove this intuitive explanation. 
 
5. Conclusions and outlook 
A general stable hybrid deterministic-stochastic nonlinear optimization and modeling 
framework for the optimal selection of enzyme levels and regulatory structures using dynamic 
kinetic models of cellular systems has been introduced, and the corresponding computational 
method has been for the first time demonstrated on a large-scale nonlinear kinetic model of 
central carbon metabolism of E. coli without any preliminary model simplification. 
Computational results show that the modification of all enzyme levels and regulatory properties 
leads to a stable 8-fold increase in the PTS uptake rate and a stable 22-fold increase in the serine 
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biosynthesis rate. Substantial improvements can be predicted by manipulating only small subsets 
of enzyme levels and regulatory structures due to the saturation property of metabolism limited 
by the protein synthesis machinery. For example, the modulation of six enzyme levels already 
leads to a flux increase of 80% of the best predicted serine flux. This means that while more 
efforts can be required to elucidate larger stable optimal enzyme level/regulation choices, no 
further significant increase in the corresponding targeted fluxes can be obtained and therefore 
such choices may not be worth the effort due to the computationally predicted loss of stability 
properties via the Hopf or saddle-node bifurcation. We have also observed a strong synergism 
between the redesign of tightly regulated enzymes (e.g. phosphofructokinase) and the 
overexpression of those enzymes that lack regulation (e.g. glyceraldehyde-3-phosphate 
dehydrogenase). The obtained nonlinear optimization results are contrasted with respect to local-
linear predictions obtained from the well-established metabolic control analysis (MCA). 
Although the implemented stochastic simulated annealing approach does not guarantee 
the convergence to the global optimal solutions and better choices can still be found, the 
solutions discussed, which have been found from a very extensive search, already provide 
valuable candidate enzyme/regulation choices. Such choices can be used in prioritizing theoretic 
and practical studies of important properties of enzymatic reactions, kinetic regulatory structures, 
and providing a systematic framework for designing experiments to better understand regulation 
of cellular function. The framework can also be used as a powerful modeling tool for the direct 
computational validation of context-dependent theoretic assumptions allowing the modeler to 
better understand how the biological mechanisms give rise to biological function. Based on this, 
the modeler can then devise experiments to test the model’s predictions of relevant modes of 
cellular function. The framework also allows for the bifurcation analysis of the critical cases 
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where the stability of the optimized regimes can be lost. Such cases additionally emphasize the 
complexity of large-scale optimization studies and the importance of the careful selection of 
stable small subsets of enzyme levels and regulatory structures for their subsequent practically 
feasible alterations.  
Originally highly nonlinear and (linlog) approximated models have been carefully 
compared in a number of previous studies (Visser et al., 2004; Vital-Lopez et al., 2006). Under 
steady-state conditions, full models and their linlog approximations lead to similar conclusions. 
However, contrasting to the previous steady-state optimization studies, we have made an 
important observation that even small amplitude optimal periodic regimes computed using full 
models can lead to a better prediction compared to those obtained for steady-states cases. It is 
important to note that the idea to use periodic regimes in bioengineering and biotechnology is not 
radically novel and was introduced and discussed long time ago in the context of frequency 
responses (Douglas, 1967; Bailey, 1973; Hatzimanikatis et al., 1993; Hatzimanikatis and Bailey, 
1996). To this end, simulation of sustained periodic DNA replication in the engineered bacterial 
strain can also be used as an important biological criterion of the feasibility of the corresponding 
metabolic engineering strategies and interventions (Atlas et al., 2008).  
We emphasize that our study of optimal dynamics regimes requires further theoretical 
and practical analysis that goes beyond the scope of this work. Specifically, as it has been earlier 
found by Vital-Lopez et.al. (2006), the observed periodic processes exist in the model within 
small parametric ranges and are very close to the boundary of the total stability loss by the 
system. Therefore, a more detailed study of practically-feasible optimal periodic states 
necessitates, at least, (i) an adequate modification of the model to include dynamic cofactors, and 
(ii) the utilization of the global stability constrains based on Lyapunov functions, which could be 
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used to estimate the geometric size of the attraction basins of the corresponding stationary and 
periodic states. In this respect we note that the idea of including stability constraints into an 
optimization formulation is now standard in control theory and, in particularly, in the model 
predictive control, and it goes well beyond the eigenvalue-type constraint used in formulation 
(10), which can only guarantee local stability. To this end, modern control approaches includes 
stability constraints based on Lyapunov (energy)-type functions (Mhaskar et al., 2005, 2006). 
Therefore, these and similar well-established and new ideas from the modern control theory need 
to be further employed in optimization modeling studies to suggest a tighter control of the 
genetically altered cellular system operation and functioning near the loss of stability properties 
under more realistic conditions in the bioreactor including spatiotemporal uncertainties such 
temperature fluctuation.  
Another important aspect of optimization-based modeling studies employing large-scale 
kinetic models is in the typical stiffness of the corresponding differential equations during the 
solution process. An important rigorous approach to reduce the model stiffness and to improve 
the computational performance while maintaining the integrity of the final results has been 
recently suggested (Gerdtzen et al., 2004). Because in many practical situations, the model’s 
stiffness can significantly complicate the model integration without any noticeable effect on the 
final results, an alternative approach to reduce the stiffness in the original (i.e. non-reduced) 
model could be the introduction of a small bias into parameter fitting procedures that would 
penalize the selection of parameter values leading to stiffness in the model nonlinear behavior 
(Brown and Sethna, 2003). 
Finally, we hope that as soon as more information on enzyme regulation becomes 
available due to the emergence of powerful inference methods like the double regulation method 
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allowing for the practical estimation of enzyme elasticities from experimental measurements 
(Link and Weuster-Boltz 2007), the discussed optimization framework and modeling strategy, 
when coupled with emerging synthetic biology methods (Elowitz and Leibler, 2000; Fung et al., 
2005; Wong and Liao, 2006), will have a broader implication in directing practically feasible 
metabolic manipulations of small numbers of key cellular functions to achieve a targeted 
metabolic engineering objective. 
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Nomenclature 
Enzymes  
ALDO   aldolase 
DAHPS   DAHP synthases 
ENO   enolase 
G1PAT   glucose-1-phosphate adenyltransferase 
G3PDH  glycerol-3-phosphate dehydrogenase 
G6PDH  glucose-6-phosphate dehydrogenase 
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GAPDH   glyceraldehyde-3-phosphate dehydrogenase 
MetSynth  methionine synthesis 
MurSynth  mureine synthesis 
PFK     phosphofructokinase 
PGDH   6-phosphogluconate dehydrogenase 
PGI   glucose-6-phosphate isomerase 
PGK   phosphoglycerate kinase 
PGM   phosphoglycerate mutase 
PDH   pyruvate dehydrogenase 
PEPxylase  PEP carboxylase 
PGlucoM phosphoglucomutase 
PK   pyruvate kinase 
PTS  phosphotransferase system 
R5PI  ribose-phosphate isomerase 
RPPK  ribose-phosphate pyrophosphokinase 
Ru5P  ribulose-phosphate epimerase 
Synth1  synthesis1 
Synth2  synthesis2 
TA  transaldolase 
TIS  triosephosphate isomerase 
TKa  transketolase A 
TKb  transketolase B 
TrpSynth tryptophan synthesis  
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Metabolites 
2pg   2-phosphoglycerate 
3pg   3-phosphoglycerate 
6pg   6-phosphogluconate 
accoa   acetyl-coenzyme  A 
dhap   dihydroxyacetonephosphate 
e4p   erythrose-4-phosphate 
f6p   fructose-6-phosphate 
fdp   fructose-1,6-bisphosphate 
g1p   glucose-1-phosphate 
g6p   glucose-6-phosphate 
gap   glyceraldehyde-3-phosphate 
glc   glucose 
oaa   oxaloacetate 
pep   phosphoenolpyruvate 
pgp   1,3-diphosphoglycerate 
pyr   pyruvate 
rib5P   ribose-5-phosphate 
ribu5p   ribulose-5-phosphate 
sed7p   sedoheptulose-7-phosphate 
xyl5p   xylulose-5-phosphate 
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TABLES 
Table 1. Enzyme regulation. 
 
№ 
 
 
Enzyme 
 
Regulation 
 
Notation 
 
1 
 
PTS 
 
 
inhibition by g6p 
 
PTS↓g6p 
 
2 
 
PGI 
 
 
inhibition by 6pg 
 
PGI↓6pg 
 
3 
 
PFK 
 
 
inhibition by pep 
 
PFK↓pep 
 
4 
 
PFK 
 
 
activation by adp 
 
PFK↑adp 
 
5 
 
PFK 
 
 
activation by amp 
 
PFK↑amp 
 
6 
 
PK 
 
 
activation by amp 
 
PK↑amp 
 
7 
 
PK 
 
 
activation by fdp 
 
PK↑fdp 
 
8 
 
 
PK 
 
inhibition by atp 
 
PK↓atp 
 
9 
 
 
G1PAT 
 
activation by nadph 
 
G1PAT↑nadph 
 
10 
 
 
G6PDH 
 
inhibition by nadph 
 
G6PDH↓nadph 
 
11 
 
 
PGDH 
 
inhibition by atp 
 
 
PGDH↓atp 
 
12 
 
 
PGDH 
 
inhibition by nadph 
 
PGDH↓nadph 
 
13 
 
 
PEPxylase 
 
activation by fdp 
 
PEPxylase↑fdp 
 Stable optimization of kinetic models 
 
 
34 
Table 2. Best flux ratios of steady state fluxes in the optimized and original models. 
   
 
 
 
 
 
 
 
 
 
Here flux ratio is the ratio of the objective function with the respect to the reference value.  
H corresponds to the Hopf bifurcation.  
Flux Regulation Enzyme Level Enzyme Level & Regulation
PTS 1.43 3.16 7.31 (8.26 H)
Serine 1.06 20.59 22.01
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Table 3. Control coefficients for regulated enzymes at the original steady state. 
№ Enzyme Modifier Regulation EEC FCC (PTS) FRC (PTS) FCC (Serine) FRC (Serine)
1 PTS g6p negative -0.978 0.416 -0.407 0.192 -0.187
2 PGI 6pg negative -0.551 0.000692 -0.000381 0.000374 -0.000206
3 PFK pep negative -2.047 0.242 -0.496 0.14 -0.287
4 PFK adp positive 0.025 0.242 0.00605 0.14 0.0035
5 PFK amp positive 0.268 0.242 0.065 0.14 0.0376
6 PK amp positive 0.000226 0.0109 0.00000246 -0.122 -0.0000275
7 PK fdp positive 0.0000682 0.0109 0.00000074 -0.122 -0.00000831
8 PK atp negative -0.0000544 0.0109 -0.0000006 -0.122 0.00000664
9 G1PAT fdp positive 0.731 0.00721 0.00527 -0.00934 -0.00683
10 G6PDH nadph negative -0.419 0.115 -0.0483 -0.0721 0.0302
11 PGDH atp negative -0.012 0.000389 -0.00000464 0.000211 -0.0000025
12 PGDH nadph negative -0.485 0.000389 -0.000189 0.000211 -0.000102
13 PEPxylase fdp positive 0.019 0.0387 0.00073 -0.126 -0.00238
 
Here EEC is Enzyme Elasticity Coefficient, FCC is Flux Control Coefficient, and FRC is Flux 
Response Coefficient, FRC = EEC·FCC (see (10) in the text). 
 Stable optimization of kinetic models 
 
 
36 
Table 4. Alternative 10 best optimal enzyme/regulation subsets for the increased PTS rate. 
 
Size 
 
 
Enzyme Subset 
 
Flux Ratio 
 
Enzyme/Regulation Subset 
 
Flux Ratio 
 
1 
 
 
PTS(+) 
 
1.073 
 
PTS↓g6p(-) 
 
1.080 
2 
 
PTS(+), RPPK/ PEPxylase (+) 1.233 PTS↓g6p(-), G1PAT↑nadph(+) 
 
1.462 
3 
 
PTS(+)  
GAPDH(+) 
PEPxylase(+)  
 
1.628 PTS↓g6p(-), G1PAT↑nadph(+) 
GAPDH(+) 
 
2.173 
4 
 
PTS(+), PFK(+) 
GAPDH(+)  
PEPxylase(+) 
 
2.246 PTS↓g6p(-),PFK↑adp(+) 
GAPDH(+) 
PEPxylase↑fdp(+) 
3.880 
5 
 
PTS(+), PFK(+) 
GAPDH(+),  
PDH(+) 
PEPxylase(+) 
 
2.541 PFK↑adp(+), ALDO(+) 
GAPDH(+),  
Ru5p(-), 
PEPxylase↑fdp(+)  
5.863 
6 PTS(+), PFK(+) 
GAPDH(+), TIS(+) 
PDH(+)  
PEPxylase(+) 
 
2.843 PTS↓g6p(-), PFK↑amp(+) 
GAPDH(+), TIS(+) 
PDH(+)  
PEPxylase↑fdp(+) 
5.550 
(new branch) 
7 
 
PTS(+), PFK(+) 
GAPDH(+), TIS(+), PGK(-) 
PDH(+)  
PEPxylase(+) 
 
2.892 PTS↓g6p(-),PFK↑amp(+), ALDO(+) 
GAPDH(+), TIS(+) 
PDH(+) 
PEPxylase↑fdp(+) 
7.314 
8 
 
PTS(+), PFK(+), ALDO(-) 
GAPDH(+), TIS(+), PGK(-) 
PDH(+)  
PEPxylase(+) 
 
2.964 PTS↓g6p(-),PFK↑amp(+), ALDO(+) 
GAPDH(+), TIS(+), PGK(+) 
PDH(+) 
PEPxylase↑fdp(+) 
7.852 (H) 
 
9 
 
PTS(+), PFK(+), ALDO(-) 
GAPDH(+), TIS(+), PGK(-) 
PDH(+), PGM(-) 
PEPxylase(+) 
 
3.048 PTS↓g6p(-), PFK↑amp(+), ALDO(+) 
GAPDH(+), TIS(+), PGK(+) 
PDH(+), PGM(-) 
PEPxylase↑fdp(+) 
 8.059 (H) 
10 
 
 
PTS(+), PFK(+), ALDO(-) 
GAPDH(+), TIS(+), PGK(-)  
PDH(+), PGM(-), ENO(-) 
PEPxylase(+) 
 
3.155 PTS↓g6p(-), PFK↑amp(+), ALDO(+) 
GAPDH(+), TIS(+), PGK(+) 
PDH(+), PGM(-), ENO(-) 
PEPxylase↑fdp(+) 
8.263 (H) 
Enzymes highlighted in bold exert high control on the PTS rate. Signature (+)/(-) corresponds to the 
increase/decrease in the corresponding enzyme property (i.e. the enzyme level or regulation), 
respectively. Flux ratio is the ratio of the objective function with the respect to the reference value. 
H corresponds to the Hopf bifurcation. 
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Table 5. Alternative 10 best optimal enzyme/regulation subsets for the serine flux.  
 
Size 
 
 
Enzyme Subset 
 
Flux 
Ratio 
 
Enzyme/Regulation Subset 
 
Flux Ratio 
 
1 
 
 
SerSynth(+) 
 
1.880 
 
G6PDH↓nadph (+) 
 
1.034 
2 
 
PTS(+) 
SerSynth (+) 
 
4.652 PTS↓g6p(-) 
SerSynth (+) 
 
4.754 
3 
 
PTS(+)  
GAPDH(+) 
SerSynth (+) 
 
9.086 PTS↓g6p(-) 
GAPDH(+) 
SerSynth (+) 
 
9.963 
4 
 
PTS(+), PFK(+) 
GAPDH(+)  
SerSynth (+) 
 
14.451 PTS↓g6p(-), PFK↑adp/amp(+) 
GAPDH(+) 
SerSynth (+) 
 
16.650 
5 
 
PTS(+), PFK(+) 
GAPDH(+)  
PDH(+) 
SerSynth (+) 
 
15.933 PTS↓g6p(-), PFK↑adp(+) 
GAPDH(+), TIS(+) 
 
SerSynth (+)  
18.518 
6 PTS(+), PFK(+) 
GAPDH(+), TIS(-)  
PDH(+) 
SerSynth (+)  
 
17.418 PTS↓g6p(-), PFK↑amp(+) 
GAPDH(+), TIS(+) 
PDH(+)  
SerSynth (+) 
20.039 
7 
 
PTS(+), PFK(+) 
GAPDH(+),TIS(-), ALDO(-) 
PDH(+) 
SerSynth (+)  
 
19.085 PTS↓g6p(-), PFK↑amp(+) 
GAPDH(+), TIS(+), ALDO(-) 
PDH(+) 
SerSynth (+) 
22.013 
8 
 
PTS(+), PFK(+) 
GAPDH(+),TIS(-), ALDO(-) 
PDH(+), PGK(-) 
SerSynth (+)  
 
19.838   
9 
 
PTS(+),PFK(+), PGI(-) 
GAPDH(+),TIS(-), ALDO(-) 
PDH(+), PGK(-) 
SerSynth (+)  
 
20.538   
10 
 
 
PTS(+), PGI(-), PFK(+) 
GAPDH(+),TIS(-), ALDO(-) 
PDH(+), PGK(-), ENO(-) 
SerSynth (+)  
 
20.591   
Enzymes highlighted in bold exert high control on the PTS rate. Signature (+)/(-) corresponds to the 
increase/decrease in the corresponding enzyme property (i.e. the enzyme level or regulation), 
respectively. Flux ratio is the ratio of the objective function with the respect to the reference value. 
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FIGURE CAPTIONS 
Figure 1. Escherichia coli central carbon metabolism. 
 
Figure 2. (a) Shown are the best optimal reaction rate ratios for the Serine biosynthesis rate 
plotted as a function of size D of modulated enzyme/regulation subsystems (i.e. D = 1, 2, …, 10). 
(b) Shown are the values of the leading real eigenvalues of the model’s linearization computed at 
optimal steady-state solutions. White circles correspond to the case where enzyme levels are 
modulated while enzyme regulation is kept unchanged. Solid circle correspond to the case where 
both enzyme levels and enzyme regulations are manipulated.  
 
Figure 3. (a) Shown are the best optimal reaction rate ratios for the PTS rate plotted as a 
function of size D of modulated enzyme/regulation subsystems (i.e. D = 1, 2, …, 10). (b) Shown 
are the values of the real parts of the leading eigenvalues of the model’s linearization computed 
at optimal steady-state solutions. White circles correspond to the case where enzyme levels are 
modulated while enzyme regulation is kept unchanged. Solid circle and triangles correspond to 
the case where both enzyme levels and enzyme regulations are manipulated. 
 
Figure 4. Flux Control Coefficients (FCCs) for the PTS reaction (white bars) and serine 
production (solid bars), respectively. 
 
Figure 5. (a) Flux Control Coefficients (FCCs) for the PTS reaction. (b) Optimal enzyme levels 
relative to the reference enzyme levels. The white bars in (a) correspond to the original non-
perturbed case as shown in Figure 4. The gray bars in (a) and (b) correspond to the case where 
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the enzyme levels are optimally chosen in the absence of any regulation alteration. The black 
bars in (a) and (b) correspond to the case where the regulatory structures for the enzymes PTS, 
PFK, and PEPxylase are altered and the levels of the enzymes TIS, GAPDH, and PDH are 
modulated. 
 
Figure 6. The distributions of stable steady state fluxes relative to the PTS flux at the reference 
non-perturbed steady state. The italic numbers correspond to the values of fluxes at the reference 
steady state. The upright numbers correspond to the values of fluxes in the case where the levels 
of all the six enzymes are modulated in the absence of any regulatory changes. The values of 
fluxes highlighted in bold correspond to the case where the regulatory structures for the enzymes 
PTS and PFK, and the levels of the enzymes TIS, GAPDH, PDH, and PEPxylase are 
simultaneously manipulated. 
 
Figure 7. (a) Flux Control Coefficients (FCCs) for the SerSynth reaction. (b) Relative enzyme 
levels at the optimal stable steady states. The white bars in (a) correspond to the original non-
perturbed case as shown in Figure 4. The gray bars correspond to the case where the enzyme 
levels are optimally chosen in the absence of any regulation alteration. The black bars 
correspond to the case where the regulatory structures for the enzymes PTS and PFK are altered 
and the levels of enzymes TIS, GAPDH, PDH, and SerSynth are simultaneously modified. 
 
Figure 8. The distributions of stable steady state fluxes relative to the PTS flux at the reference 
state. The italic numbers correspond to the values of fluxes at the reference steady state. The 
upright numbers correspond to the values of fluxes in the case where the levels of all the six 
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enzymes are modulated in the absence of any regulatory changes. The values of fluxes 
highlighted in bold correspond to the case where the regulatory structures for the enzymes PTS 
and PFK, and the levels of the enzymes TIS, GAPDH, PDH, and SerSynth are simultaneously 
modified.  
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